+43.0%
GSK vs SEDG
-94.0%
+136.9%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | SEDG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.3% | -6.7% | +4.4% | -2.1% |
| 7D | -3.0% | -16.0% | +13.0% | -2.5% |
| 30D | +0.4% | -30.7% | +31.1% | +1.4% |
| 3M | -1.2% | -29.5% | +28.3% | -0.4% |
| 6M | +0.9% | -64.8% | +65.8% | +3.5% |
| YTD | +4.0% | -24.7% | +28.7% | +2.7% |
| 1Y | +7.3% | -36.6% | +43.9% | +6.6% |
| 3Y | +57.1% | -72.5% | +129.6% | +53.2% |
| 5Y | +43.0% | -94.0% | +137.0% | +52.7% |
| All | +43.0% | -94.0% | +136.9% | +52.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SEDG.
Daily Out/Under-Performance
Portfolio return minus SEDG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SEDG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded SEDG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling